证券代码：688135 证券简称：利扬芯片 公告编号：2026-021 转债代码：118048 转债简称：利扬转债 广东利扬芯片测试股份有限公司2025年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 二、经营业绩和财务状况情况说明 （一）报告期的经营情况、财务状况及影响经营业绩的主要因素 1、经营情况：2025年公司实现营业收入为61,839.44万元，较上年同期增长26.69%；实现归属于母公司 所有者的净利润为-919.83万元；实现归属于母公司所有者的扣除非经常性损益的净利润为-1,162.47万 元。 2、财务状况：2025年期末，公司总资产为264,120.73万元，较期初增长1.87%；归属于母公司的所有者 权益为114,294.99万元，较期初增长3.27%；归属于母公司所有者的每股净资产为5.62元,较期初增长 1.63%。 3、影响经营业绩的主要因素： 本公告所载2025年度主要财务数据为初步核算数据，未经会计师事务所审计，具体数据以广东利扬芯片 测试股份有限公司（以下简称"公司"）20 ...

证券研究报告 东吴证券晨会纪要 东吴证券晨会纪要 2026-02-25 [Table_Tag] 宏观策略 [Table_MacroStrategy] 金融产品周报 20260207：海外市场流动性有企稳迹象，情绪或会好转【勘 误版】 市场行情展望：（2026.2.2-2026.2.6） 观点：市场短期进入结构混沌期， 但大盘指数仍然稳健。 2 月整体走势判断：2026 年 2 月，宏观择时模 型的月度评分是 0 分，历史上该分数万得全 A 指数后续一个月上涨概率 为 78.57%，平均涨幅为 3.37%。叠加日历效应中财报预告的结束，我们 对 2 月 A 股大盘走势持乐观的观点。但鉴于 1 月权益已累计不少盈利盘， 春节前可能有一定的止盈压力。 本周 A 股中，宽基 ETF 仍在持续流出, 但能观察到 1 月 30 日多数宽基 ETF 呈现明显成交额缩小的特征，说明 后续来自宽基 ETF 的抛压可能会逐步减小。同时通信、芯片、化工、石 油石化、港股非银等方向呈现资金流入的特征，可以关注后续资金的持续 性。 结构上，市场短期呈现混沌期特点。上周提示过的周期性行业表现 相对不错，石油、化工等方向仍旧较为稳健。但有 ...

中国经济网北京2月24日讯 利扬芯片(688135.SH)近日发布2025年年度业绩预告。 经利扬芯片财务部门初步测算，预计2025年年度将出现亏损，实现归属于母公司所有者的净利润 为-1,150.00万元至-850.00万元，与上年同期（法定披露数据）相比，将减少亏损5,311.87万元到5,011.87 万元；预计2025年年度实现归属于母公司所有者的扣除非经常性损益的净利润为-1,350.00万元至-950.00 万元；与上年同期（法定披露数据）相比，将减少亏损5,218.08万元到5,618.08万元。 利扬芯片于2025年6月24日发布股东询价转让结果报告书暨持股5%以上股东权益变动触及5%整数倍的 提示性公告。本次询价转让的转让方为黄兴、海南扬致企业管理合伙企业（有限合伙）（以下简称"扬 致投资"）、海南扬宏企业管理合伙企业（有限合伙）（以下简称"扬宏投资"）、黄主、谢春兰，出让 方均非利扬芯片控股股东、实际控制人，其中扬致投资为利扬芯片董事、财务总监、董事会秘书担任执 行事务合伙人的员工持股平台；扬宏投资为利扬芯片控股股东、实际控制人担任执行事务合伙人的员工 持股平台，扬宏投资、黄主、黄兴及谢春 ...

Core Viewpoint - The company, Feilo Acoustics (600651), has outlined its core business segments, which include smart hardware products, solutions, and inspection and testing services [1] Group 1: Business Segments - The smart hardware segment encompasses automotive lighting, automotive electronics and electrical appliances, module packaging, chip testing services, and precision component manufacturing [1]

Core Viewpoint - The company has confirmed that it is experiencing tight testing capacity in some product lines, leading to potential price increases for certain customers who are requesting them [1] Group 1 - The company has been asked about its collaboration with Huawei's Ascend chips, indicating interest in partnerships within the industry [1] - The company stated that it will decide on price increases based on its strategic development, suggesting a proactive approach to market demand [1]

Core Viewpoint - Liyang Chip (688135.SH) plans to raise up to 970 million yuan through a private placement of A-shares, with the funds allocated for various projects and working capital [1][3]. Fundraising Details - The total amount to be raised is capped at 970 million yuan, which will be used for the following projects: - East City Liyang Chip Integrated Circuit Testing Project: 70 million yuan out of a total investment of 131.52 million yuan - Wafer Laser Hidden Cutting Project (Phase I): 8 million yuan out of a total investment of 10 million yuan - Heterogeneous Stacking Advanced Packaging Technology R&D Project: 10 million yuan fully funded by the raised capital - Supplementing working capital and repaying bank loans: 9 million yuan fully funded by the raised capital [1][3][4]. Issuance Methodology - The shares will be issued as domestic listed ordinary shares (A-shares) with a par value of 1.00 yuan each, and the issuance will be conducted through a private placement to no more than 35 specific investors [3][4]. - The pricing will be set at no less than 80% of the average trading price over the 20 trading days prior to the pricing date [4]. Shareholder and Control Information - The issuance will not change the control of the company, as Huang Jiang remains the controlling shareholder and actual controller post-issuance [6][11]. - The shares subscribed by the specific investors will be subject to a six-month lock-up period after issuance [5][6]. Historical Context - Liyang Chip was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 11, 2020, with an initial public offering that raised approximately 536 million yuan [6][7]. - The company has faced financial challenges, with a projected net loss for 2025 between 85 million yuan and 115 million yuan, although this represents a reduction in losses compared to the previous year [8].

南方财经2月2日电，利扬芯片(688135.SH)1月31日披露2026年度向特定对象发行A股股票预案，计划向 不超过35名特定投资者发行股票，募集资金总额不超过97,000万元，用于扩展集成电路测试产能及先进 工艺研发。募集资金在扣除发行费用后拟投入四个项目：其中70,000万元用于东城利扬芯片集成电路测 试项目，旨在扩大芯片测试服务能力；8,000万元用于晶圆激光隐切项目（一期），拓展晶圆切割业 务；10,000万元用于异质叠层先进封装工艺研发项目，联合叠铖光电开发高端图像传感芯片技术；9,000 万元用于补充流动资金及偿还银行贷款，以优化财务结构。财务数据显示，利扬芯片2024年度归属于母 公司股东的净利润为-6,161.87万元，但2025年经营状况改善，1-9月实现归属于母公司股东的净利润 75.47万元，扣除非经常性损益后为-191.44万元，公司称已在2025年第三季度末实现连续两季度盈利。 公司首次公开发行股票募集资金净额47,094.26万元已于2025年9月30日使用完毕，主要用于芯片测试产 能建设、研发中心及补充流动资金，其中芯片测试产能建设项目累计实现收益33,279.12万元，但未达 ...

以下文章来源于格隆汇交易学苑 ，作者格隆汇小编 格隆汇交易学苑 . 以基本面为基础，专注于趋势交易 投资赛道中，每一轮产业浪潮均孕育着"现象级"产业链核心资产：AI算力爆发期光模块领跑，光伏装机热潮中逆变器乘风而起。我们从价值 量、产业链地位、技术壁垒、个股优势四大维度出发，带大家一同尝试探寻2026年的潜力标的。 半导体测试是芯片出厂前的"最后一道安检"，直接决定良率与可靠性。在全球产业链向中国转移、"China for China"策略推动订单回流的背 景下，第三方测试凭借规模效应与灵活适配性，逐步抢占外资份额。 作为内资第三方高端测试龙头 ，伟测科技（下称公司）聚焦高算力、高可靠性芯片测试，用业绩爆发验证成长逻辑，正从内资标杆向全球竞争 力企业跨越。 公司以逆周期产能布局卡位核心风口，凭AI+车规双引擎兑现业绩爆发力，叠加多维竞争壁垒与明确增长催化， 正成为 2026年 最具潜力的大 牛股备选标的。 业绩爆发验证潜力：前三季度盈利翻倍式增长 01 2025年前三季度，伟测科技交出超预期答卷，大牛股的业绩基因全面显现。 公司实现营业收入10.83亿元，同比增长46.22%；净利润2.02亿元，同比激增22 ...

Core Viewpoint - The article highlights the potential of Weicet Technology as a leading player in the high-end semiconductor testing industry, driven by significant growth in revenue and profit, strategic capacity expansion, and favorable market conditions leading up to 2026 [1][11]. Group 1: Financial Performance - In the first three quarters of 2025, Weicet Technology reported a revenue of 1.083 billion yuan, a year-on-year increase of 46.22%, and a net profit of 202 million yuan, which surged by 226.41% [2][3]. - The operating cash flow net amount reached approximately 500 million yuan, reflecting a year-on-year growth of 66%, providing a solid foundation for capacity expansion [2][3]. - In Q3, the company achieved a revenue of 448 million yuan, a quarter-on-quarter increase of 28% and a year-on-year increase of 44.40%, with a net profit of 101 million yuan, marking a year-on-year growth of 98.11% [5]. Group 2: Business Segmentation and Growth Drivers - The high-end testing business accounted for 75% of total revenue in the first three quarters, indicating a continuous optimization of the product structure [5]. - The computing power segment's revenue doubled compared to the previous year, while the automotive-grade business revenue approached double that of the previous year, showcasing strong partnerships with major manufacturers [5][7]. - The company’s strategic focus on high computing power and automotive-grade chip testing aligns with industry trends, allowing it to capitalize on growth opportunities [6][9]. Group 3: Strategic Positioning and Competitive Advantages - Weicet Technology's competitive edge stems from its strategic foresight and execution, with a focus on high-end testing equipment and capacity expansion during industry downturns [6][9]. - The company has invested 1.8 billion yuan in capital expenditures in the first three quarters, maintaining a leading position in domestic capacity [6][9]. - The overall capacity utilization rate exceeded 95%, with the Shanghai base operating at full capacity, indicating strong operational efficiency [7]. Group 4: Future Catalysts - The global AI computing power is expected to reach 1271.4 EFLOPS by 2026, driving demand for high-end testing solutions [9]. - The company anticipates high capacity utilization in Q4, with new equipment coming online to meet increasing orders, particularly from AI and automotive sectors [9]. - Cost structure optimization is expected to enhance profitability, with depreciation costs projected to decrease as high-end capacity utilization increases [9].

Group 1 - Fudan Microelectronics (688385) announced a significant change in its major shareholder, with Shanghai Guosheng Group Investment Co., Ltd. (Guosheng Investment) set to acquire 107 million A-shares from Shanghai Fuxin Fangao Integrated Circuit Technology Co., Ltd. (Fuxin Fangao), representing 12.99% of the total shares at a price of 5.144 billion yuan, or 48.20 yuan per share [1] - Following the transfer, Guosheng Investment will become the largest shareholder of Fudan Microelectronics, while the company will remain without a controlling shareholder or actual controller, ensuring no significant impact on its management [1] - Guosheng Investment's rationale for the acquisition is aligned with its strategic development needs, with its controlling shareholder being Shanghai Guosheng Group and actual controller being the Shanghai State-owned Assets Supervision and Administration Commission [1] Group 2 - A framework agreement for the share transfer was signed on November 14, with both parties agreeing to maintain and support the strategic cooperation between Fudan Microelectronics and Fudan University, focusing on collaborative research and development in cutting-edge technology fields such as integrated circuits [2] - The agreement includes plans to establish diversified research cooperation platforms and to support joint team formation, technology breakthroughs, and resource sharing, emphasizing a collaborative model that integrates basic research, technological development, and industrial transformation [2] - To ensure operational continuity and stability of core business, both parties will work together to maintain the stability of senior management and key personnel within Fudan Microelectronics [2] Group 3 - The share transfer is subject to internal decision-making approvals from both parties, regulatory approvals from state-owned asset supervision authorities, and compliance confirmation from the Shanghai Stock Exchange before the transfer can be registered [3] - Fudan Microelectronics is recognized as a leading domestic chip design company with a diverse product line, including security and identification chips, non-volatile memory, smart meter chips, and field-programmable gate arrays (FPGAs), and it also provides chip testing services through its subsidiary, Hualing Co., Ltd. [3]